New Approach Methodologies (NAMs): By the numbers

Globally, biopharmaceutical companies are shifting toward non-animal approaches in drug discovery and development. But many R&D teams don’t know how to meet regulatory expectations or integrate these new technologies effectively. With more than 190 million animals used in scientific research each year and regulatory agencies signaling a future in which animal studies become the exception, the need for practical, robust alternatives has never been more urgent.

Certara’s Non-Animal Navigator™ was created to guide that transition. By combining toxicology consulting, advanced in silico modeling, and tailored regulatory strategies, we can help you reduce reliance on animal testing. In addition, this solution helps our clients improve translational confidence, optimize study designs, and accelerate development timelines.

This infographic introduces the current landscape of animal use, highlights the growing momentum behind NAMs, and shows how the Non-Animal Navigator can help you chart a path toward a more ethical, efficient, and human-relevant future in drug development.